A detailed history of Simplex Trading, LLC transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 113 shares of CSBR stock, worth $780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113
Previous 3,004 96.24%
Holding current value
$780
Previous $15,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$3.95 - $5.14 $11,419 - $14,859
-2,891 Reduced 96.24%
113 $0
Q2 2024

Jul 25, 2024

BUY
$4.5 - $5.23 $6,331 - $7,358
1,407 Added 88.1%
3,004 $15,000
Q1 2024

Apr 25, 2024

BUY
$4.9 - $6.91 $7,825 - $11,035
1,597 New
1,597 $7,000
Q3 2023

Nov 01, 2023

BUY
$5.2 - $7.32 $5,532 - $7,788
1,064 New
1,064 $6,000
Q2 2022

Aug 03, 2022

BUY
$6.81 - $8.31 $640 - $781
94 New
94 $0

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $93.4M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.